omniture
DeepQure

Latest News

DeepQure Announces Robust 3-Month Results from HERO-HTN Clinical Study at EuroPCR 2026

PARIS, May 20, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, today announ...

2026-05-20 22:00 5353

DeepQure Reports Encouraging Clinical Data from World's First Extravascular RDN System at AUA 2026

WASHINGTON, May 14, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, announc...

2026-05-15 02:30 3364

DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment

SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- DeepQure, a company pioneering a paradigm shift i...

2025-09-03 10:52 2671

MFDS Clears DeepQure's HyperQure™ for Clinical Trial in Atrial Fibrillation

SEOUL, South Korea, July 17, 2025 /PRNewswire/ -- DeepQure announced today that South Korea's Minis...

2025-07-18 10:59 2692

DeepQure Advances Global Clinical Trials for Innovative RDN Technology

SEOUL, South Korea, March 3, 2025 /PRNewswire/ -- Breaking Barriers in Hypertension Treatment DeepQ...

2025-03-04 09:46 2782

DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertens...

2024-10-29 21:00 2856

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™)

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company wi...

2024-06-10 13:14 3227